Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-09-16 Exercise | 2024-09-17 5:12 pm | N/A 2025-02-28 | C4 Therapeutics Inc. | CCCC | Boyle Scott N Chief Business Officer | 2,250 | $0 | 68,169 (Direct) | View |
| 2024-09-16 Tax Withholding | 2024-09-17 5:12 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | Boyle Scott N Chief Business Officer | 661 | $6.36 | 68,169 (Direct) | View |
| 2024-03-07 Option Award | 2024-03-08 7:28 pm | N/A 2032-01-02 | C4 Therapeutics Inc. | CCCC | Boyle Scott N Chief Business Officer | 115,000 | $0 | 115,000 (Direct) | View |
| 2024-03-07 Disposition | 2024-03-08 7:28 pm | N/A 2032-01-02 | C4 Therapeutics Inc. | CCCC | Boyle Scott N Chief Business Officer | 115,000 | $0 | 115,000 (Direct) | View |
| 2024-02-13 Tax Withholding | 2024-02-15 5:03 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | Boyle Scott N Chief Business Officer | 1,735 | $6.53 | 175,130 (Direct) | View |
| 2024-02-14 Option Award | 2024-02-15 5:03 pm | N/A 2034-02-13 | C4 Therapeutics Inc. | CCCC | Boyle Scott N Chief Business Officer | 150,100 | $0 | 175,130 (Direct) | View |
| 2023-09-18 Option Award | 2023-09-19 7:23 pm | N/A 2033-09-17 | C4 Therapeutics Inc. | CCCC | Boyle Scott N Chief Business Officer | 120,000 | $0 | 120,000 (Direct) | View |
| 2023-08-30 Exercise | 2023-08-31 4:09 pm | N/A 2025-02-28 | C4 Therapeutics Inc. | CCCC | Boyle Scott N Chief Business Officer | 2,250 | $0 | 43,265 (Direct) | View |
| 2023-08-30 Tax Withholding | 2023-08-31 4:09 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | Boyle Scott N Chief Business Officer | 661 | $2.93 | 43,265 (Direct) | View |
| 2023-02-13 Option Award | 2023-02-15 4:45 pm | N/A 2033-02-12 | C4 Therapeutics Inc. | CCCC | Boyle Scott N Chief Business Officer | 110,000 | $0 | 115,176 (Direct) | View |
| 2023-01-30 Exercise | 2023-02-01 4:10 pm | N/A 2025-02-28 | C4 Therapeutics Inc. | CCCC | Boyle Scott N Chief Business Officer | 3,750 | $0 | 23,926 (Direct) | View |
| 2023-01-30 Tax Withholding | 2023-02-01 4:10 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | Boyle Scott N Chief Business Officer | 1,222 | $7.78 | 23,926 (Direct) | View |
| 2022-05-26 Tax Withholding(A) | 2022-06-14 4:45 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | Boyle Scott N Chief Business Officer | 1,102 | $7.01 | 2,648 (Direct) | View |
| 2022-05-25 Exercise | 2022-05-27 4:15 pm | N/A 2025-02-28 | C4 Therapeutics Inc. | CCCC | Boyle Scott N Chief Business Officer | 3,750 | $0 | 26,250 (Direct) | View |
Ownership | 2022-03-17 4:18 pm | N/A 2032-01-02 | C4 Therapeutics Inc. | CCCC | Boyle Scott N Chief Business Officer | 0 | $0 | 141,250 (Direct) | View |